Gu M - Search Results

1

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking.

Zhang TX, Duan XC, Cui Y, Zhang Y, Gu M, Wang ZY, Li WY. Zhang TX, et al. Among authors: gu m. Front Oncol. 2024 Apr 2;14:1376502. doi: 10.3389/fonc.2024.1376502. eCollection 2024. Front Oncol. 2024. PMID: 38628672 Free PMC article.

2

Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.

Li W, Yue W, Zhang L, Zhao X, Ma L, Yang X, Zhang C, Wang Y, Gu M. Li W, et al. Among authors: gu m. Lung. 2012 Feb;190(1):91-8. doi: 10.1007/s00408-011-9338-8. Epub 2011 Nov 23. Lung. 2012. PMID: 22109568

3

Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer.

Teng Y, Wang Z, Ma L, Zhang L, Guo Y, Gu M, Wang Z, Wang Y, Yue W. Teng Y, et al. Among authors: gu m. Onco Targets Ther. 2016 Jul 7;9:4151-62. doi: 10.2147/OTT.S105732. eCollection 2016. Onco Targets Ther. 2016. PMID: 27462170 Free PMC article.

4

Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.

Li W, Yue W, Wang H, Lai B, Yang X, Zhang C, Wang Y, Gu M. Li W, et al. Among authors: gu m. Oncol Lett. 2016 Nov;12(5):3836-3844. doi: 10.3892/ol.2016.5207. Epub 2016 Sep 29. Oncol Lett. 2016. PMID: 27895738 Free PMC article.

5

DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.

Zhang J, Zhang X, Zhao X, Jiang M, Gu M, Wang Z, Yue W. Zhang J, et al. Among authors: gu m. Tumour Biol. 2017 Jul;39(7):1010428317703820. doi: 10.1177/1010428317703820. Tumour Biol. 2017. PMID: 28677426 Free article.

6

Cyclophilin A promotes non-small cell lung cancer metastasis via p38 MAPK.

Guo Y, Jiang M, Zhao X, Gu M, Wang Z, Xu S, Yue W. Guo Y, et al. Among authors: gu m. Thorac Cancer. 2018 Jan;9(1):120-128. doi: 10.1111/1759-7714.12548. Epub 2017 Nov 7. Thorac Cancer. 2018. PMID: 29110442 Free PMC article.

7

Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype.

Xu J, Zhao X, He D, Wang J, Li W, Liu Y, Ma L, Jiang M, Teng Y, Wang Z, Gu M, Wu J, Wang Y, Yue W, Zhang S. Xu J, et al. Among authors: gu m. J Cancer Res Clin Oncol. 2018 Aug;144(8):1413-1422. doi: 10.1007/s00432-018-2668-7. Epub 2018 May 24. J Cancer Res Clin Oncol. 2018. PMID: 29797219

8

Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients.

Ma L, Gu M, Teng Y, Li W. Ma L, et al. Among authors: gu m. Onco Targets Ther. 2019 Jan 29;12:921-932. doi: 10.2147/OTT.S180507. eCollection 2019. Onco Targets Ther. 2019. PMID: 30774378 Free PMC article.

9

PD-L1⁺ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients.

Zhang L, Zhang X, Liu Y, Zhang T, Wang Z, Gu M, Li Y, Wang DD, Li W, Lin PP. Zhang L, et al. Among authors: gu m. Cancer Lett. 2020 Jan 28;469:355-366. doi: 10.1016/j.canlet.2019.10.041. Epub 2019 Oct 31. Cancer Lett. 2020. PMID: 31678168 Free article.

10

Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation.

Zhang T, Li W, Gu M, Wang Z, Zhou S, Hao X, Li W, Xu S. Zhang T, et al. Among authors: gu m. Cancer Manag Res. 2021 Apr 28;13:3539-3550. doi: 10.2147/CMAR.S305179. eCollection 2021. Cancer Manag Res. 2021. PMID: 33953608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,455 results

Search Page

Filters